DESITIN PHARMA A/S: Financial statements 2016
CVR: 19389006
Source: annual report 2016, Danish Business Authority
01/10/2015 – 30/09/2016
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 5,603,913 and a net result of DKK 1,189,111 compared with DKK 2,362,269 the year before. That is a decrease of 24.4% compared with the year before. Equity in the 2016 report amounted to DKK 3,722,987. The solvency ratio was 76.4%.
- Gross Profit
- DKK 5,603,913
- Profit/Loss
- DKK 1,189,111
- Equity
- DKK 3,722,987
- Total Assets
- DKK 4,871,759
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 5.6 mio. | 1.2 mio. | 3.7 mio. | - |
| 2015 | - | 7.4 mio. | 2.4 mio. | 3.7 mio. | - |
| 2014 | - | 958 t. EUR | 287 t. EUR | 379 t. EUR | - |
| 2013 | - | 881 t. EUR | 209 t. EUR | 342 t. EUR | - |
Official annual report
Find more companies like DESITIN PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,151,761 and a net result of DKK 288,733 compared with DKK 285,567 the year before. Equity in the 2025 report amounted to DKK 7,044,140.